Zhuang J.a· Wu Q.a· Yang X.a· Cai L.a· Li K.a· Hua H.b· Bao M.b· Yu R.a· Liu P.a· Li P.a· Cao Q.a· Lu Q.a

Author affiliations

aDepartment of Urology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China
bDepartment of Pathology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China

Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent via DeepDyve Unlimited fulltext viewing of this article Organize, annotate and mark up articles Printing and downloading restrictions apply

Start free trial

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview

Received: June 22, 2022
Accepted: January 22, 2023
Published online: March 08, 2023

Number of Print Pages: 5
Number of Figures: 2
Number of Tables: 1

ISSN: 0042-1138 (Print)
eISSN: 1423-0399 (Online)

For additional information: https://www.karger.com/UIN

Abstract

Angiomyolipoma (AML) complicated with tumour thrombus extending to the confluence of inferior vena cava (IVC) with right atrium is rarely observed. We report a female AML patient admitted to our centre on January 21, 2020, with complication of tumour thrombus extending to the confluence of IVC with right atrium and had no sign of difficult breathing. She underwent whole-abdominal enhanced CT for abdominal pain and was diagnosed with a possible renal AML with tumour thrombus. Open radical nephrectomy and thrombectomy of vena cava were performed. Intraoperative transoesophageal echocardiography indicated that the tumour thrombus has reached the confluence of IVC with right atrium. The operation took 255 min with an intraoperative haemorrhage of 800mL. The patient was discharged 7 days after surgery. Pathology revealed lipoma-like AML. Immunohistochemistry showed vimentin (+), EMA (−), HMB45 (+), S-100 (−), SMA (+), TFE-3 (−), melan A (+). After 2 years of follow-up, we found that the patient showed full recovery and had no recurrence. Therefore, lipoma-like AML should also be followed closely for recurrence and metastasis. When AML involves IVC tumour thrombus, open thrombectomy and radical nephrectomy are safe and effective methods.

© 2023 S. Karger AG, Basel

References Bhatt JR, Richard PO, Kim NS, Finelli A, Manickavachagam K, Legere L, et al. Natural history of renal angiomyolipoma (AML): most patients with large AMLs >4 cm can be offered active surveillance as an initial management strategy. Eur Urol. 2016 Jul;70(1):85–90. Bissler JJ, Kingswood JC. Renal angiomyolipomata. Kidney Int. 2004 Sep;66(3):924–34. Al Otaibi M, Abou Youssif T, Alkhaldi A, Sircar K, Kassouf W, Aprikian A, et al. Renal cell carcinoma with inferior vena caval extention: impact of tumour extent on surgical outcome. BJU Int. 2009 Nov;104(10):1467–70. Flum AS, Hamoui N, Said MA, Yang XJ, Casalino DD, McGuire BB, et al. Update on the diagnosis and management of renal angiomyolipoma. J Urol. 2016 Apr;195(4 Pt 1):834–46. Que X, Zhu Y, Ye C, Bi D, Fan J, Ding S, et al. Invasive epithelioid angiomyolipoma with tumor thrombus in the inferior vena cava: a case report and literature review. Urol Int. 2017;98(1):120–4. Nese N, Martignoni G, Fletcher CD, Gupta R, Pan CC, Kim H, et al. Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney: a clinicopathologic study of 41 cases: detailed assessment of morphology and risk stratification. Am J Surg Pathol. 2011 Feb;35(2):161–76. Janík M, Hejna P. Renal cell carcinoma pulmonary embolism: a rare cause of sudden death. Forensic Sci Med Pathol. 2015 Sep;11(3):468–71. Wang B, Li H, Ma X, Zhang X, Gu L, Li X, et al. Robot-assisted laparoscopic inferior vena cava thrombectomy: different sides require different techniques. Eur Urol. 2016 Jun;69(6):1112–9. Chopra S, Simone G, Metcalfe C, de Castro Abreu AL, Nabhani J, Ferriero M, et al. Robot-assisted level II–III inferior vena cava tumor thrombectomy: step-by-step technique and 1-year outcomes. Eur Urol. 2017 Aug;72(2):267–74. Lim RS, Flood TA, McInnes MDF, Lavallee LT, Schieda N. Renal angiomyolipoma without visible fat: can we make the diagnosis using CT and MRI? Eur Radiol. 2018 Feb;28(2):542–53. Kostibas MP, Arora V, Gorin MA, Ball MW, Pierorazio PM, Allaf ME, et al. Defining the role of intraoperative transesophageal echocardiography during radical nephrectomy with inferior vena cava tumor thrombectomy for renal cell carcinoma. Urology. 2017 Sep;107:161–5. Satelli A, Li S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci. 2011 Sep;68(18):3033–46. Saoud R, Kristof TW, Judge C, Chumbalkar V, Antic T, Eggener S, et al. Clinical and pathological features of renal epithelioid angiomyolipoma (PEComa): a single institution series. Urol Oncol. 2022 Feb;40(2):18–24. Wang D, Liu M, Li Y, Xie M. Right renal angiomyolipoma with intracardiac extension and pulmonary embolism. J Clin Ultrasound. 2021 Jun;49(5):516–9. Roberts SI, Ladi-Seyedian S, Daneshmand S. Vena cava tumor thrombus associated with renal angiomyolipoma in a jehovah’s witness patient. Urology. 2021 Oct;156:e86–7. Lee G, Nabavizadeh R, Osunkoya AO, Master VA. A rare case of vena cava tumor thrombus associated with epithelioid angiomyolipoma. Urology. 2020 Aug;142:e4–7. Kassimi M, Amriss O, Guerroum H, Habi J, Belhaj K, Mahi M. Renal angiomyolipoma with renal vein extension. Radiol Case Rep. 2021 Aug;16(8):2325–7. Kheir P, Abdessater M, El Khoury J, Akiel R, El Hachem C, Tawil N, et al. Renal angiomyolipoma with IVC thrombus: a case report. Int J Surg Case Rep. 2020;70:149–53. Gupta D, Vishwajeet V, Pandey H, Singh M, Sureka B, Elhence P. Epithelioid angiomyolipoma with tumor thrombus in IVC and right atrium. Autops Case Rep. 2020 Sep 2;10(4):e2020190. Mettler J, Al-Katib S. Aggressive renal angiomyolipoma in a patient with tuberous sclerosis resulting in pulmonary tumor embolus and pulmonary infarction. Urology. 2018 Sep;119:e1–2. Gu J, Zeng L, Zeng H, Qin C, Wu Z. A rare case of renal angiomyolipoma involved both inferior vena cava and pulmonary arteries. J Thorac Dis. 2018 Mar;10(3):E166–9. Majdoub AE, Khallouk A, Farih MH. Aggressive renal angiomyolipoma extending to the renal vein: about a case and literature review. Pan Afr Med J. 2017;28:190. Article / Publication Details

First-Page Preview

Received: June 22, 2022
Accepted: January 22, 2023
Published online: March 08, 2023

Number of Print Pages: 5
Number of Figures: 2
Number of Tables: 1

ISSN: 0042-1138 (Print)
eISSN: 1423-0399 (Online)

For additional information: https://www.karger.com/UIN

Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.